Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415344
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-16
First Post:
2024-05-10
Brief Title:
Long-term Extension of GTX-102 in Angelman Syndrome
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Ultragenyx Pharmaceutical Inc
Organization Data
Organization:
Ultragenyx Pharmaceutical Inc
Class:
INDUSTRY
Study ID:
GTX-102-CL302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ultragenyx Pharmaceutical Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None